Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brand Drug Price Increases Continue To Slow, Latest AARP Data Show

This article was originally published in The Pink Sheet Daily

Executive Summary

Branded pharmaceutical prices increased 6.6% on average for the 12 month period ended March 2005, a drop from the 7.1% average increase reported for the year ended December 2004.

You may also be interested in...

Brand Name Drug Prices Increased 7.1% In 2004, AARP Report Says

The latest "Rx Watchdog Report" says wholesale acquisition cost for 195 brand name drugs increased at double the rate of general inflation. Prices for 75 generic drugs rose 0.5%, less than one-fifth the inflation rate. A PhRMA study found consumer medical costs increased 4.7%, compared to 4% for branded and generic drugs.

PhRMA Studies Contest AARP Drug Price "Watchdog Report"

Milliman study commissioned by PhRMA shows prescription drug CPI increased .9% in first quarter, lower than the 3.4% figure cited by AARP based on wholesale acquisition cost. Muse & Associates study shows Medicare drug discount cards offer average savings of 16.2% over cash prices available in November.

Celgene To Submit Revlimid Phase III Special Protocol Assessment For CLL To FDA Shortly

Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts